Retrospective study to confirm the efficacy and safety of carbon ion radiotherapy in intermediate-risk prostate cancer

Retrospective study to confirm the efficacy and safety of carbon ion radiotherapy in intermediate-risk prostate cancer - Retrospective study to confirm the efficacy and safety of carbon ion radiotherapy in intermediate-risk prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054515

Enrollment

2400

Registered

2024-05-30

Start date

2024-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Pateinsts who received carbon ion radiotherapy for intermediate-risk prostate cancer at QST Hospital from January 2000 to March 2024.

Exclusion criteria

Exclusion criteria: Cases in which the secondary use of clinical data is refused when obtaining consent for treatment or other research, and cases in which the research subject or his/her representative refuses the use of clinical data in this research.

Design outcomes

Primary

Measure	Time frame
overall survival	—

Secondary

Measure	Time frame
adverse events, local control rate, biochemical recurrence-free survival, QOL	—

Countries

Japan

Contacts

Public ContactKana Kobayashi

National Institutes for Quantum Science and Technology Dept. of Treatment and diagnosis

kobayashi.kana@qst.go.jp0432063306

Outcome results